EMA closes PIM Project

On March 28, 2011, EMA announced the closure of the PIM project.  This is disappointing news but not totally unexpected.  With the resources and funding available, EMA needs to concentrate on programmes that are driven by legislation, such as upgrading Eudravigilance and the associated identification listing of all medicinal products in the EU by July 2012, as defined within the new pharmacovigilance legislation.  I am convinced that at some point PIM, or ‘son-of-PIM’ will return but it may be several years before EMA can prioritise this.  In the meantime there is still a business case within industry for structured content authoring of product information documents, even if the output for EU remains QRD complaint MS Word documents for the time-being.